Tokyo, Oct. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059467) titled 'Influenza viral shedding after treatment with and anti-influenza drug : 2025-2026 Season' on Oct. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Japan Physicians Association Influenza Study Group
Condition:
Condition - Influenza
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate viral persistence after treatment with an anti-influenza drug
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients diagnosed as influenza with a rapid antigen detection kit
Key exclusion criteria - None
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 05 Month 21 Day
Date of IRB - 2025 Year 09 Month 16 Day
Anticipated trial start date - 2025 Year 11 Month 04 Day
Last follow-up date - 2026 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068017
Disclaimer: Curated by HT Syndication.
